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Abstract
Bovine tuberculosis (bTb) remains a major and economically important disease of livestock. Improved ante-mortem
diagnostic tools would help to underpin novel control strategies. The definition of biomarkers correlating with disease
progression could have impact on the rational design of novel diagnostic approaches for bTb. We have used a murine bTb
model to identify promising candidates in the host transcriptome post-infection. RNA from in vitro-stimulated splenocytes
and lung cells from BALB/c mice infected aerogenically with Mycobacterium bovis were probed with high-density
microarrays to identify possible biomarkers of disease. In antigen-stimulated splenocytes we found statistically significant
differential regulation of 1109 genes early (3 days) after infection and 1134 at a later time-point post-infection (14 days). 618
of these genes were modulated at both time points. In lung cells, 282 genes were significantly modulated post-infection.
Amongst the most strongly up-regulated genes were: granzyme A, granzyme B, cxcl9, interleukin-22, and ccr6. The
expression of 14 out of the most up-regulated genes identified in the murine studies was evaluated using in vitro with
antigen-stimulated PBMC from uninfected and naturally infected cattle. We show that the expression of cxcl9, cxcl10,
granzyme A and interleukin-22 was significantly increased in PBMC from infected cattle compared to naı¨ve animals
following PPD stimulation in vitro. Thus, murine transcriptome analysis can be used to predict immunological responses in
cattle allowing the prioritisation of CXCLl9, CXCL10, Granzyme A and IL-22 as potential additional readout systems for the
ante-mortem diagnosis of bovine tuberculosis.
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Introduction
Bovine tuberculosis (bTb), mainly caused by mainly by Mycobac-
terium bovis, remains an economically important disease of livestock
such as cattle [1] and is also a disease of zoonotic importance. Host
biomarkers for bTb are needed urgently in several areas to underpin
disease control strategies. For example, correlates of disease and/or
pathology could improve the sensitivity of immunological ante-
mortem diagnosis which is at present mainly based on tuberculin
skin testing and ancillary blood tests. Furthermore, predictors of
protection and correlates of protective immunity after vaccination
would greatly facilitate vaccine development.
Although IFN-c production has been a useful tool for the blood-
based detection of M. bovis infection in cattle and other species
[2,3,4] as well as for the detection of M. tuberculosis infected
humans, additional biomarkers could improve the accuracy of in
vitro blood tests [5]. For example, it has been shown recently that
simultaneous measurement of antigen-stimulated IL-1b and TNF-
a production enhances IFN-c test sensitivity to diagnose bTb in
cattle [6]. Previously, we have shown in a mouse model of M. bovis
infection that studying cellular immune responses in BCG
vaccinated compared to control animals can guide the study of
corresponding responses found in cattle [7]. Therefore, in the
present study we applied a systematic approach to discover
potential diagnostic biomarkers based on the definition of
biomarkers in a cost-effective murine bTb model followed by
validation of promising markers in cattle.
The paucity of reagents for cattle for the study of immunolog-
ically relevant markers by antibody-based assays such as the
luminex multiplex system applied to human tuberculosis (e.g. [8]),
makes host transcriptome analysis in cattle an attractive
alternative. Therefore, in this study we report our application of
microarray technology in combination with murine M. bovis
infection experiments to select the most strongly up-regulated
genes expressed from the whole transcriptomes of lung and spleen
cells to predict biomarkers of disease in M. bovis infected cattle.
Results
Gene expression profiling of early disease in spleen and
lung from mice infected with M. bovis
In order to identify potential biomarkers of tuberculosis
infection, two groups of 5 BALB/C mice each were infected with
M. bovis. After 3 and 14 days post-infection (p.i.) mice were
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euthanized and their splenocytes stimulated in vitro for 3 days with
a protein pool of seven defined mycobacterial antigens, termed
M7. Lung cells were collected and stimulated only at the 14 day
p.i. time point. Following stimulation the fold change of gene
expression was established using Whole Mouse Genome Oligo
Microarrays. First, we compared the global transcriptional
response in the spleen of mice infected with M. bovis against
uninfected mice, and genes were considered significant when their
corrected p-values were below 0.05 with more than a 2-fold
change of expression. In antigen-stimulated splenocytes we found
significant modulation of 1109 genes early after infection (day 3
p.i., Table S1) and 1134 at later time-point post-infection (day 14
p.i.) (Table S1). Unsupervised hierarchical cluster was performed
using a centered linkage with a Person centered measure showing
that 618 of these genes were modulated at both time points
(Figure 1). Amongst the genes most strongly up-regulated at both
time points p.i. was granzyme A (gzmA) with 21-fold and 26-fold
changes in expression in infected animals compared to naı¨ve
controls after 3 days and 14 days p.i. respectively (Table 1).
Amongst the genes significantly modulated only at 14 days p..i.
were histocompatibility 28 (H28), and ubiquitin D, suggesting that
they are associated with early disease progression (data not shown).
In antigen-stimulated lung cells we found 282 genes that were
significantly modulated after 14 days post-infection (see Table S2
for list of genes and Figure 2 for heat-map of this signature of 282
genes). As expected [9], ifn-c was strongly up-regulated (82-fold) in
the lungs of infected animals after 14 days p.i. compared with
naı¨ve mice. Following the same trend were il-22 and cxcl9 with 74-
fold and 22-fold change in their expression, respectively (Tables 1
and S2). Other genes that were differentially expressed in lungs
after M. bovis infection were granzyme B, lymphocyte activation
gene-3, il-17E receptor, and ccr6 (Tables 1 and S2).
Pathway Analysis
Pathway Analysis using IPA was performed on the 282 genes
that were significantly modulated in antigen-stimulated lung cells
after 14 days post-infection. The two most significantly associated
canonical pathways were related to T Helper Cell Differentiation
(2log[p-value] = 9.47E00 and ratio = 1.53E201) and B Cell
Development (2log[p-value] = 7.88E00 and ratio = 1.53E201)
(Figure 3A). The five networks most significantly associated with
these genes were inflammatory response (60 genes, p-va-
lue = 2.83E215), Cell-To-Cell Signalling and Interaction (63
genes, r-value= 2.95E215), Cellular Growth and Proliferation
Figure 1. Spleen gene signature after 3 and 14 days after infection withM. bovis. The global transcriptional response in spleen cells of mice
infected with M. bovis was compared to responses in uninfected mice. Genes were considered significantly modulated when their corrected p-values
were below 0.05 with more than 2-fold change of expression at both time points. After 3 and 14 days post-infection (blue square and red squares,
respectively at the bottom of graph), the mice were euthanized and their splenocytes were stimulated in vitro for 3 days with M7 protein pool (see
Materials and Methods). Black squares: Naı¨ve control mice. Unsupervised hierarchical cluster was performed using a centroid linkage with a Person
centered measure showing that 618 of these genes were modulated at both time points (see table S1 for list of these genes, with genes significantly
modulated at both time points highlighted in bold).
doi:10.1371/journal.pone.0030626.g001
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(77 genes, p-value = 8.2E215) and Hematological System Devel-
opment and Function (76 genes, p-value = 8.2E215) (Figure 3B).
In antigen-stimulated splenocytes at 3 and 14 days p.i. we found
statistically significant modulation of genes associated with the
following dominant canonical pathways contained genes associat-
ed with T cell receptor Signalling (3 days p.i.: 2log[p-
value] = 5.65E+00 and ratio = 1.65E201; 14 days p.i.: 2log[p-
value] = 7.8E00 and ratio = 1.93E201) and iCOS-iCOSL Signal-
ing in T Helper Cells (3 days p.i.: 2log[p-value] = 4.83E00 and
ratio = 1.39E201; 14 days p.i.: 2log[p-value] = 6.84E00 and
ratio = 1.64E201) (Figure 4A). Statistically significant modulation
of genes of the following networks was also observed: Inflamma-
tory Response (3 days p.i.: 175 genes, r-value = 7.51E223; 14
days p.i.: 194 genes, p-value = 4.35E233), Cellular Growth and
Proliferation (3 days p.i.: 278 genes, p-value = 1.73E222; 14 days
p.i. : 289 genes, p-value = 2.51E231), Hematological System
Development and Function (3 days p.i.: 219 genes, p-va-
lue = 7.51E223; 14 day p.i.: 235 genes, p-value = 2.51E231),
Tissue Morphology (3 days p.i. : 130 genes, p-value = 7.51E223;
14 days p.i.: 142 genes, p-value = 1.59E206), and Cell Death (3
days p.i.: 210 genes, p-value = 2.47E219; 14 days p.i.: 227 genes,
p-value = 2.09E228) (Figure 4B).
Interestingly, when the networks and pathways associated with
infection at the 14 days p.i. time point were compared between
lung and spleen, the genes enriched in these pathways showed up-
regulated expression in lung cells. In contrast, the same networks
and pathways in spleen cells were enriched for genes whose
expression was down-regulated. For example; whilst in the lungs
the inflammatory response network is mainly represented by up-
regulated genes, down-regulated genes dominate in the same
network in spleen cells. Similarly, up-regulated genes were
enriched in the T helper cell differentiation canonical pathway
in lungs from infected mice, but in spleens the genes enriched in
the same canonical pathway were predominantly regulated genes
(Figure 5A and B).
Validation of differential gene expression in natural
infected cattle by qPCR
Our principal translational objective was the identification of
biomarkers with potential application for blood-based ante-
mortem diagnosis of bTb in cattle. Based on our previous results
[10,11], we hypothesized that results obtained in our mouse
model could guide the selection of such markers for cattle. Thus,
we evaluated the expression of a selection of genes most strongly
up-regulated in the mouse experiments described above (Table 1)
in cattle using PBMC from uninfected and cattle naturally
infected with M. bovis. Apart from genes expressed in the lung of
infected mice (14 days p.i.), we also selected genes from the
murine spleen that were up-regulated both early and late after
infection (3 and 14 days p.i.). IL17A was included as positive
control as it had been shown previously to be associated with
infected cattle [10,12,13]. RNA was prepared from PBMC
cultures stimulated with PPD-B and the expression of these genes
evaluated by qRT-PCR. The results are shown in Table 1. Five
Table 1. Expression of the most up-regulated genes found in the murine model in cattle using PBMC from uninfected (bTb-free,
n = 9) and naturally with M. bovis infected cows (bTb, n = 11).
Mouse data Bovine PBMC data
Gene Name Gene bTb Free bTb r-value
Symbol Lung
Mean ± SEM
of Log(FC)
Mean ± SEM
of Log(FC)
14 days p.i.
Interferon gamma IFN-c 82.54 0.06860.30 2.12260.19 ,0.0001*
Interlukin-22 IL-22 74.15 0.12560.32 2.21560.20 0.0002*
Chemokine (C-X- motif) ligand 9 Cxcl9 23.8 0.14960.24 2.49260.26 ,0.0001*
Interleukin-17Aa IL-17A NA 0.50960.33 1.7360.13 0.0052
Chemokine (C-X- motif) ligand 10 Cxcl10 22.13 0.07960.19 1.62660.28 0.0004*
Lymphocyte-activation gene 3 Lag3 12.11 0.43660.31 0.22860.18 0.582
Signal transducer and activator of transcription 1 Stat1 3.15 0.23460.11 0.46660.17 0.3746
Granzyme B GzmB 5.84 20.16760.19 20.24260.09 0.7249
Interferon regulatory factor Irf4 4.25 0.27560.21 0.20060.13 0.7664
Interferon gamma inducible protein 47 Ifi47 4.14 0.00860.02 0.08960.17 0.7964
Interleukin-17 receptor E receptor IL-17RE 3.99 0.56760.36 20.28560.32 0.1638
Spleen
3 days p.i. 14 days p.i.
Granzyme A GzmA 21.27 26.58 20.23260.35 1.24560.23 0.0029*
Acetylgalactosamin transferase 3 Galnt3 19.21 13.34 20.16760.19 20.24260.09 0.7249
Adenosine deaminase Ada 18.42 12.09 20.64160.12 20.66960.26 0.9366
Killer cell lectin-like receptor subfamily K member 1 Klrk1 5.02 4.81 1.20660.59 20.05860.39 0.1141
The data are represented as mean (6 SEM) fold changes in expression after stimulation of PBMC with bovine PPD-B. Significance level for comparison of results in bTb-
free and infected animals: p -value#0.0033 (*).
aUsed as positive control.
NA, not applicable.
doi:10.1371/journal.pone.0030626.t001
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of the 14 genes selected based on the murine transcriptome
analyses described above were found to be also significantly up-
regulated in bovine PBMC from infected animals compared to
naı¨ve controls. The most highly modulated genes were those
encoding IFN-c, IL22, CXCL9, CXCL10, and GzmA (Table 1).
The other 9 genes studied were not significantly modulated in
bovine PBMC from infected animals (Table 1). The gene
encoding for IL17A was also expressed stronger in bTb infected
cattle compared to TB-free cows, although its expression was not
quite statistically significant (P = 0.0052, Table 1).
When we compared the expression of the genes encoding IFN-
c, IL22, CXCL9, CXCL10, GzmA, and IL17A, we did not find
correlations between their expression the disease severity
described by the pathology scores [14] assigned after post mortem
examinations of the infected cattle (data not shown). However,
this study was not designed primarily to correlate expression
levels with disease severity and we therefore acknowledge that its
statistical power was not sufficient to avoid type 2 errors. Larger
animal numbers, including experimentally infected cattle need to
be tested to validate this hypothesis in greater details.
In a final set of experiments we determined the phenotype of the
bovine T cell subset(s) that transcribed the genes for IL22, IL17A
and GzmA. IFN-c in this system is exclusively produced by CD4+
T cells (Vordermeier, unpublished data) and was used as control.
Highly enriched CD4+, CD8+ and TCRcd+ (cd+) T cell subset
populations were isolated by FACS sorting and co-cultured in the
presence of CD14+ monocytes were as APC and PPD-B. The
expression of these genes was determined 24 hours later by qRT-
PCR. The results (Fig. 6) demonstrated that ifn-c and il22 were
expressed by bovine CD4+ T cells. However, whilst il17A was also
predominantly expressed by CD4+ cells; CD8+ and cd+ T cells also
expressed some il17A albeit an order of magnitude less. Granzyme
A expression could be detected in both CD4+ and CD8+ T cell
subsets (Figure 6).
Figure 2. Pulmonary gene signature after 14 days after infection with M. bovis. The global transcriptional response in the lung of mice
infected with M. bovis was compared the response of uninfected mice. Genes were considered significant when their correct p-value were below 0.05
with more than 2-fold change of expression. After 14 days post-infection the mice were euthanized and their lung cells were stimulated in vitro for 3
days with M7 protein pool (see Materials and Methods). Unsupervised hierarchical cluster was performed using a centroid linkage with a Person
centered measure showing that 282 of these genes were modulated (see table S2 for list of these genes).
doi:10.1371/journal.pone.0030626.g002
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Discussion
BTb remains an economically import disease of livestock species
and improved diagnostic tests would benefit the implementation of
control strategies. Transcriptomics approaches have been used to
identify gene expression profiles to define biomarkers of TB in
mice, primates and humans in different infection conditions.
Several recent publications have reviewed these studies [15,16].
Likewise, studies in cattle, aiming to determine gene expression
profiling, have been reviewed by Waters et. al. [17] focusing on ex
vivo studies and macrophage infection. Yet, the interaction between
host and M. bovis, which result in bTb, remains poorly
characterized in cattle. The definition of such biomarkers induced
after infection could have impact on the rational design of novel
diagnostic approaches. We have used the advantages of the
murine model (cheap, relatively short experimental periods,
availability of reagents, detailed genome annotation) to study the
host transcriptome after M. bovis infection. As we hypothesised our
analysis has lead to the validation in cattle of a number of
biomarkers found in the murine system which include the genes
encoding IL22, IL17A and Gzm A. PPD-B was used to stimulate
bovine PBMC because it is the standard antigen used to diagnose
bTb in livestock. In contrast, a protein cocktail (M7) was used to
stimulate mouse lymphocytes because PPD-B is a poor antigen to
stimulate murine responses despite the presence of these proteins
in PPD-B (Hogarth et al., unpublished observation). The reasons
underlying this discrepancy in antigenic activity between the two
species are not clear at present. Furthermore, the objective was to
define bovine biomarkers applicable to routine ante-mortem blood
based bTb diagnosis in cattle. Therefore, we targeted our analysis
to peripheral blood as the only practical sample that can be
collected readily from cattle in the field.
Interestingly, we could not validate in cattle the over-expression
of all genes that we prioritised based on the mouse experiments.
This could be due to the fact that we studied peripheral blood
responses in cattle, whilst the mouse studies concentrated on
Figure 3. Functional networks (A) and canonical pathways (B) most significantly modulated in lung cells 14 days after M. bovis
infection. Visualization of the trend and significance in the regulation of each network and pathway. Dark blue: all genes represented in a network.
Light blue: genes that were up-regulated in a network. Cyan: gene those were down-regulated in a network. Fisher’s exact test threshold value of
p#0.05.
doi:10.1371/journal.pone.0030626.g003
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tissues (lung and spleen). In addition, the infection status is likely
different between the two species populations studied: Murine
responses were assessed relatively early after infection, whilst the
time of infection in the cattle studied cannot be defined as these
animals were naturally infected and are likely composed of a very
heterogeneous group. It is therefore possible that not all responses
found at the tissue sites of infection are reflected in the blood.
However, our results demonstrated the value of the mouse system
to guide the study of gene expression in cattle.
Our data also suggested that the networks and pathways
associated both in lungs and spleen with infection at the 14 days
p.i. time point showed up-regulated expression in the lung whilst
the same networks and pathways in spleen cells were enriched for
genes whose expression was down-regulated. This could be
explained by sequestration of particular cell populations into the
lungs as principal site of infection as we previously proposed [18].
As our principal objective was to define bovine biomarkers useful
for the ante-mortem diagnosis of bTb in cattle, we concentrated
on the validation of potential markers that were strongly up-
regulated in spleen and lung cells to allow the assessment of the
widest selection of markers possible. In addition to their over-
expression in mice, we also selected genes for validation in the
bovine system on those whose products would have the potential
to be detected by antibody-based assay systems such as ELISA.
This lead therefore to the prioritisation of markers such as
chemokines and cytokines.
Figure 4. Functional networks (A) and canonical pathways (B) most significantly modulated in spleen cells 3 and 14 days after
M. bovis infection. Visualization of the trend and significance in the regulation of each network and pathway are shown. Specific networks and
pathways after 3 (dark blue bars) or 14 days p.i. (light blue bars) are indicated. Fisher’s exact test threshold value of p#0.05.
doi:10.1371/journal.pone.0030626.g004
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IL-22 belongs to the IL-10 cytokine family and is produced by
NK cells, mast cells, and T cells, especially Th17 and Th22 cells. It
is involved in the antimicrobial defence of mucosal surfaces
including in the airway by promoting innate immunity to bacterial
infection. IL-22 has been shown to induce genes encoding
antimicrobial proteins, b-defensins, S100 calcium binding proteins
and to up-regulate the expression of chemokine (ccl1, cxcl5 and
cxcl9) and cytokine genes (il-6 and g-csf). Furthermore, the
functional consequences of IL-22/IL22R signalling can be
potentiated by IL-17A/F and TNF-a in order to promote the
expression of many of the genes encoding molecules involved in
host defence in the lung [19]. The specific role of IL-22 in M.
tuberculosis infection remains undefined, although it has been
reported that IL-22 did not have a significant role in host
protection and granuloma formation in mice [20,21]. In contrast,
the production of IL-22 by human NK cells or addition of
recombinant IL-22 to infected macrophages enhanced phagoly-
sosomal fusion and reduces growth of M. tuberculosis [22]. In
addition, CD4+ T effector cells bearing membrane-bound IL-22
(IL22+ CD4+ T cells) significantly reduced intracellular M.
tuberculosis replication in macrophages isolated from rhesus
macaques [23]. Whether IL-22 contributes to control TB at the
site of infection is unknown. Nevertheless, active TB is associated
with lower frequencies of IL17+ and IL22+ CD4+ T cells in
peripheral blood [24]. In contrast, we have also demonstrated
elevated expression of IL22 in lymph nodes from infected cattle
(Aranday-Cortes et al., unpublished).
The role of IL17A in human tuberculosis has been described
(reviewed in [25,26]. Although IL-17 might not play an equally
important role in protection against mycobacterial infections as
IFN-c [27], recent studies have shown that IL-17 mediates an
inflammatory response through granulopoiesis and consequent
neutrophil accumulation. This may be required for protective
immunity in the early stage of infection but could also become
detrimental if its production remains high during later stages of
disease [28]. In addition, IL-17 is reported to play an essential role
Figure 5. Induction of the inflammatory response network in lung (A) and spleen (B) cells at 14 days p.i. Dark blue: all genes enriched in
this network. Light blue: genes that were up-regulated in this network. Cyan: gene those were down-regulated in this network.
doi:10.1371/journal.pone.0030626.g005
Figure 6. Phenotypic analysis of bovine T cell subsets that
expressed the genes encoding for IL22, IL17a and GzmA. Highly
purified CD4+, CD8+, and CD82/TCRd+ T cell populations were isolated
by FACS sorting and the mRNA expression of these genes was
determined after stimulation with PPD-B. Results are presented as mean
fold increase compared to media control values 6 SEM.
doi:10.1371/journal.pone.0030626.g006
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in the formation of granulomas in mice infected with BCG [29]
and reduced Th17 CD4 T cell numbers are associated with PPD-
induced impaired cytokine response in patients with HIV [30]. IL-
17 producing cd T cells were increased in patients with active
pulmonary tuberculosis [31]. Interestingly, we have recently
described a role for IL17A in the protective immune responses
against bTb in cattle after BCG and BCG/viral subunit prime-
boost experiments both in cattle [10] and mice [11]. In cattle its
expression was up-regulated in protected animals after vaccination
but before challenge and can therefore be defined as predictor of
protection [10]. In this study we now also define it as a marker of
disease progression in cattle and mice. Our data therefore are in
agreement with an earlier report by Blanco et al. [13] who
reported that il-17 expression was positively associated with
pathology in cattle. Thus, our observations also support the notion
that IL-17A is involved both in immune processes leading to
protection or immunopathology of tuberculosis.
Granzyme A is the most abundant of the cytotoxic granules
released by cytotoxic T cells (CTL) and NK cells. It can induce cell
death independently of caspase activation [32,33] and T cells can
reduce intracellular growth of M. tuberculosis by perforin and Fas/
Fas ligand independent mechanism even in IFN-c and TNF-a
deficient mouse models [34,35]. One hypothesis which explains
these observations, is that Th17/Th22 T cells may play a role in
the pulmonary inflammatory response post-infection, by helping to
elicit a pathogenic inflammatory response involving the activation
of CTL. A similar relationship between TH17 cells and CD8+
CTL has been described in tumour immunology [36].
Whilst it is acknowledged that IL-17A and IL-22 are produced
not only by CD4+ T cells, but also by CD8+ and cd T cells (as well
as NK, NKT and non-T cells, which were not evaluated in this
study) [37,38,39,40,41], our data demonstrated that both
cytokines were predominantly expressed by CD4+ T cells with a
minor il-17A response also attributable to cd T cells. It is therefore
tempting to speculate that the responding bovine CD4+ T cells
belong to Th17 and/or Th22 subsets comparable to those
described in other species [42,43]. Granzyme A was expressed
equally in CD4+ and CD8+ which is suggestive of the induction of
CTL of both T cell subsets following bTb infection of cattle.
Comparison between spleen samples obtained at 3 and 14 days
p.i. and lungs samples at 14 days p.i. demonstrated that 32 genes
were significantly modulated in all three sets of samples (Tables S1
and S2, genes highlighted with asterisk). Interestingly, only 4/32
genes were up-regulated (ubiquitin, lymphocyte antigen 6
complex, fmrd4 and ccr5). CCR5 is a chemokine receptor that
binds CCL3, CCL4 and CCL5. The interaction between CCR5
and CCL5 may play an early protective role in limiting M.
tuberculosis growth by recruiting T-cells, NK and macrophages to
the lungs [44]. Further, reduction in number and frequency of
Th1/Th17 CCR5+ T cells was associated with reduced IFN-c and
IL-2 PPD responses in HIV-infected patients [30]. In contrast,
severe TB in juvenile rhesus monkeys was associated with the up-
regulation of ccr5 (as well as il-22 and other inflammatory
cytokines and receptors) [45]. Thus, its precise role in tuberculosis
is therefore unclear to-date.
Chemokines such as CXCL10 have been used as additional
read-outs for blood-based IFN-c release assays of human
tuberculosis [46,47]. Its application increased overall test sensitiv-
ity compared to IFN-c alone [48]. Measuring cxcl9 and cxcl10
expression by qRT-PCR has also been reported as potential
platform to increase diagnostic sensitivity in human tuberculosis
[49]. It is therefore interesting that we could show up-regulation of
both of these genes also in murine lung cells and in bovine PBMC.
Further validation of our results in cattle will determine whether
these, or the other genes validated in cattle such as il-22 or their
protein products, will increase the accuracy of blood-based
diagnostic tests for bTb when applied alongside IFN-c release
assays. However, the biomarkers identified in our study have so far
been prioritised only based on their increased gene expression
levels. Confirmation of their increased production at the protein
level will be needed to turn them into valid diagnostic tests for
bTb. Development of such antibody-based detection systems is
now part of the process of translating our findings into practical
such as ELISA-based, diagnostic tests for bTb.
In conclusions, we have shown that biomarkers defined in the
murine system can be used to guide the analysis of biomarkers of
disease in cattle. Further, we have prioritised a number of
cytokines and chemokines as potential additional diagnostic
markers for the blood based ante-mortem diagnosis of bTb to
improve traditional IFN-c release assays.
Materials and Methods
Ethics
This study and all procedures were approved by the Animal
Health and Veterinary Laboratories Agency (AHVLA) Animal
Use Ethics Committee (UK Home Office PCD 70/6905) and
performed under appropriate personal and project licences within
the conditions of the Animals (Scientific Procedures) Act 1986. All
animals were housed in appropriate biological containment
facilities at the AHVLA.
Animals
Mice. Female BALB/C mice were obtained from SPF
facilities at Charles River Laboratories, Margate, UK.
Cattle. Heparinized blood samples were obtained from 11
naturally infected single intradermal comparative tuberculin test
(SICTT)-positive reactors from herds know to have bTb. Infection
was confirmed by the presence of visible pathology at post-mortem
and the culture of M. bovis from tissues from these animals
according to previously described procedures [14]. Uninfected
controls: Heparinized blood sample were obtain from 9 SICTT-
negative animals from bTb-free herds. They were also negative in
the standard Bovigam IFN-c release assay (Prionics, Switzerland).
Antigens
Cattle. Purified protein derivative from M. bovis (PPD-B,
Prionics, Switzerland) was used in culture at 10 mg/ml for
stimulating bovine Peripheral blood mononuclear cells (PBMC).
Staphylococcal enterotoxin B (SEB, Sigma-Aldrich, UK) was used
as a positive control at 1 mg/ml.
Mice. Antigen cell culture stimulations in mice were
performed using an equal pool of seven secreted, immunogenic
recombinant mycobacterial proteins (Rv1886c, Rv3019c, Rv3763,
Rv3804c, [Lionex GmbH, Germany] Rv0251, Rv0287 and
Rv0288 [Proteix s.r.o., Czech Republic]) common to M. bovis
and BCG, referred here as M7 protein cocktail. We have
previously shown that M7 induced strong and representative T
cell responses in both vaccinated and infected mice [18]. Each
protein was used at final concentration of 2 mg/ml in 3-day
culture. Concanavalin A (Sigma-Aldrich) was used as a positive
control at 5 mg/ml for murine cells.
Mycobacterial challenge
Mycobacterium bovis isolate AF2122/97 was grown to mid log
phase in Middlebrook 7H9 broth supplemented with 4.16 g/L
pyruvic acid, 10% (v/v) oleic acid, albumin, dextrose, and catalase
(OADC) and 0.05% (v/v) Tween 80, subsequently stored at
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280uC, was used for all virulent challenges. Two groups of 5 mice
each were challenged with approx 600 CFU via the intranasal
route [50]. At days 3 and 14 post challenge five mice per group
were euthanized and spleens and lungs harvested aseptically.
Cell isolation
Spleen and lung cells were prepared by as described previously
[18] and suspended at 56106/ml spleen cells and 56105/ml lung
cells. After stimulation, cells were washed (3006 g, 5 min at room
temperature) and supernatants removed. One ml of Trizol
(Invitrogen, Paisley, UK) was then added and the cell lysates
were stored at 280uC.
Bovine PBMC. PBMC were isolated from heparinized blood
by Histopaque-1077 (Sigma-Aldrich) gradient centrifugation. Cells
were resuspended at 16106/ml in tissue culture medium (RPMI
1640 [Sigma-Aldrich] supplemented with 10% fetal calf serum
[Sigma-Aldrich], nonessential amino acids [Sigma-Aldrich],
100 U/ml penicillin and 100 mg/ml streptomycin sulfate) and
incubated overnight with PPD-B or SEB in 24-well tissue culture
plates (Life Technologies, UK). The following day, plates were
centrifuged (3006 g, 5 min at room temperature) and the
supernatant was removed. One ml of Trizol was then added
and the cell lysates were stored at 280uC.
RNA extraction from bovine PBMC
Total RNA was extracted from PBMCs using TRIzol according
to the protocol recommended by the manufacturer. Turbo DNA-
free (Ambion, Huntingdon, UK) was used to remove genomic
DNA contamination. The purity and concentration of RNA were
evaluated by NanoDrop 1000 (Thermo Scientific, Horsham, UK).
RNA with a ratio of A260/A280$1.7 was used for the RT-qPCR
validation study.
Cell Sorting
Cell sorting was performed using a Beckman Coulter MoFlo
Astrios instrument. Bovine PBMCs were stained and sorted
according to expression of the bovine T-cell surface markers CD4,
CD8 and cd TCR. The anti-bovine CD8 antibody (clone CC63)
was supplied directly conjugated to Fluorescein isothiocyanate
(AbD-Serotec, Kidlington, UK), whilst the anti-bovine CD4
antibody (clone CC8, AbD-Serotec) was custom conjugated to
R-Phycoerythrin (Invitrogen). The anti-TcR-d antibody (clone
GB21A, VMRD, Pullman, WA) was used in the primary staining
reaction as an unconjugated antibody and then labelled in a
secondary staining reaction using an isotype specific anti-mouse
IgG2b antibody directly conjugated to Alexa Fluor 633 (Invitro-
gen). Staining reactions were performed at 4uC for 15 minutes.
CD14-positive cells were isolated using magnetic beads (Miltenyi
Biotech, Bisley, UK) as described previously [51] and used as
antigen-presenting cells. The purities of the sorted T cell
populations were .99.% for CD4+CD82 cells; .96% for TcR-
d+ CD82 cells and .99.0% for TcR-d2 CD8+ cells. In the assays,
16106 sorted T cell populations were incubated for 24 h with
16105 APC in 24-well plates in the presence of PPD-B and RNA
processed as described above.
Murine RNA preparation and microarray hybridization
Spleen and lung cells were collected into Trizol and stored at
280uC until further processing. RNA was isolated from spleen
and lung cells derived from control and infected mice using
standard RNA extraction protocols (Miltenyi Biotech). The quality
of RNA samples was assessed using the Agilent 2100 Bioanalyzer
platform (Agilent Technologies, UK). All RNA samples revealed
acceptable RNA Integrity Number (RIN) values of between 7.4
and 9.6. For the linear T7-based amplification step, 0.06 mg–
0.5 mg of each total RNA samples was used as starting material.
To produce Cy3-labeled cDNA, RNA samples were amplified and
labeled using the Agilent Low RNA Input Linear Amp Kit
(Agilent Technologies) following the manufacturer’s protocol.
Yields of cRNA and the dye-incorporation rate were measured
in a ND-1000 Spectrophotometer (Thermo Scientific). In general,
control samples were labeled with Cy3 and experimental samples
were labeled with Cy5. The hybridization procedure was
performed according to the Agilent 60-mer oligo microarray
processing protocol using the Agilent Gene Expression Hybrid-
ization Kit. Briefly, 825 ng Cy3- and Cy5-labeled fragmented
cDNA in hybridization buffer was hybridized overnight (17 hours,
65uC) to Agilent Whole Mouse Genome Oligo Microarrays
4x44K using Agilent’s recommended hybridization chamber and
oven. Finally, microarrays were washed once with 66SSPE buffer
(3.6 M NaCl, 0.2 M NaH2PO4, 0.02 M EDTA pH 7.4) contaning
0.005% N-lauroylsarcosine for 1 min at room termperature
followed by a second wash with preheated 0.066 SSPE buffer
(37uC) containing 0.005% N-lauroylsarcosine for 1 min. The last
washing step was performed with acetonitrile for 30 seconds.
Normalization, filtering procedures and data analysis
Fluorescence signals of the hybridized Agilent Microarrays were
detected using Agilent’s Microarray Scanner System. Agilent’s
Feature Software (FES) was used to read out and process
microarray image files. The software determines feature intensities
(including background subtraction), rejects outliers and calculates
statistical confidences. For determination of differential gene
expression FES derived output data files were further analyzed
using GeneSpring GX 11.5 (Agilent Technologies). After baseline
transformation to mean of control samples (spleen and lung from
uninfected mice), we decided to focus on those genes that reliably
change their expression, then we filtered the microarrays following
three conditions: 1) Filter by value. Genes that do not have
normalized signal intensity values of more than 20.5 and 0.5 were
disregarded. 2) Filter by flags. All the genes with flags values present
in at least 100% of the values in any 1 out of the 3 conditions were
considered. 3) Filter by percentile. All the genes with raw signal
intensity values between 25 and 100 in any 1 out of the 3
conditions were also considered. Finally, all the genes in
coincidence between filtering by flags group and filtering by
percentile group were kept for statistical analysis.
After filtering, parametric analysis of variance was applied to
compare mean expression levels in each analysis. Data were
considered significant when the Benjamini Hochberg false
discovery rate (FDR) for the comparison under analysis was
,0.05, and the significance level was ,0.05. In order to focus on
highly regulated genes, we also restricted the majority of the
analysis to genes with changes in expression levels of at least 2.0-
fold change (FC) in all the conditions. All data set can be
downloaded from Gene Expression Omnibus public data base at
www.ncbi.nml.nih.gov/geo/ with the GEO accession number
GSE33058.
Lists of genes resulting from these analyses were submitted to
Ingenuity Pathway Analysis (IPA; IngenuityH Systems, USA,
www.ingenuity.com). In order to identify the most significant
functional networks (biological functions and diseases) and
canonical pathways related to each comparison, the analysis was
performed using the following strategy: A core analysis was
performed with all the genes with r#0.05 and fold change $2 for
each comparison; then for the same comparisons a core analysis
was performed only considering those genes that showed p#0.05
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and were at least 2 fold up-regulated. Further and independently a
last core analysis was performed for those genes with p#0.05 that
were at least 2-fold down-regulated. Finally, these analyses were
compared. Fisher’s exact test with a threshold value of p#0.05 was
used in all the analyses. The rationale behind this strategy is to
visualize the trend and significance in the regulation for each
network and pathway. Thus, we show three columns for each
comparison: one showing all the genes related to a specific network
and pathway, followed by two extra columns showing how the
networks and pathways are enriched by up- or down-regulated
genes.
Reverse transcriptase and quantitative Real-time PCR
validation
cDNA from PBMCs was synthesized from total RNA samples
using random primers and reverse transcription with SuperScript
III Vilo reverse transcriptase following the manufacturers protocol
(Applied Biosystem, Paisley, UK). cDNA from cell sorting was
synthesized using mMACS One-step cDNA Kit (Miltenyi Biotec)
following manufacturers instructions. Transcripts were quantified
by qPCR with Fast SYBR Green master mix (Applied Biosystem)
following manufactures conditions. qPCR analysis was performed
using the ABI 7500 Fast Real Time PCR System (Applied
Biosystem) in triplicate from media control, PPD-B and SEB-
stimulated PBMCs cDNA. The fold increase was calculated by
comparison with the expression of endogenous controls genes
SDHA and G3PDH using the 22DDct calculation [52].
Statistical analysis
Responses between cattle naturally infected with M. bovis and
naı¨ve controls were analysed by Student’s t-test on log transformed
data using Prism (Graph Pad, USA). To control for type I errors
due to multiple comparison, the Bonferroni’s correction for
multiple tests was applied and the significance level set at
p,0.003.
Supporting Information
Table S1 Significant modulation of spleen cell genes
early after 3 days p.i. (1109) and at later time-point of 14
days p.i. (1134). Genes in bold (618) were modulated at both
time points. Ns = no significant expression at this time point. The
genes marked with (*) result common after comparison between
spleen samples after 3 and 14 days p.i. and lungs samples after 14
days p.i. with M. bovis showed expression of (32).
(XLS)
Table S2 Significant modulation of spleen cell genes
early after 3 days p.i. (1109) and at later time-point of 14
days p.i. (1134). Genes in bold (618) were modulated at both
time points. Ns = no significant expression at this time point. The
genes marked with (*) result common after comparison between
spleen samples after 3 and 14 days p.i. and lungs samples after 14
days p.i. with M. bovis showed expression of (32).
(XLS)
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